Oriental Beauty Valley Life Messenger Gene Drug Base¶
东方美谷·生命信使基因药物创新产业基地
Incubator | Fengxian | Research checked 2026-11-04
AI and industry focus: Health, AI for Science.
Opened in April 2025 in Fengxian to connect gene and nucleic-acid drug R&D, AI-assisted molecular design, shared laboratories and pilot manufacturing. Confirm biosafety level, cleanroom specs and admission terms.
Evidence S062. “东方美谷·生命信使”基因药物创新产业基地今天正式开园_东方美谷.
Status and support¶
Published entity; intake to confirm
No standard cash award, fee waiver or equity percentage is verified for this entry. Request the current written offer.
Contact and location¶
Official evidence and authority route
Use the official website to request the responsible team and current application route. Email addresses are not reproduced in this publication.
Map position uses a district or campus anchor; it is not a verified office location.
Application workflow¶
Editorial application checklist. The current official notice or agreement controls the actual procedure.
- Describe the prototype, required equipment, process and testing needs.
- Ask for a technical review, facility visit and itemized quotation.
- Agree access, safety, sample and IP ownership, test scope and acceptance.
- Separate the facility contract from investment or public-funding applications.